全膝关节置换术治疗终末期膝骨关节炎遗传风险特征:一项全基因组关联研究
基于英国生物银行16,032例因原发性膝骨关节炎行初次全膝关节置换术患者的全基因组关联研究,发现7个与终末期膝骨关节炎显著相关的遗传位点,遗传因素所致OR为1.12(95%CI 1.10-1.14),低于BMI(OR=1.81;95%CI 1.78-1.83)和年龄(OR=2.38;95%CI 2.32-2.45)的OR;遗传因素OR在<60岁患者中大于≥60岁患者(p=0.002)。
要点
- 7个遗传位点与终末期膝骨关节炎显著相关,涉及软骨发育、稳态、细胞信号和代谢基因。
- 遗传因素OR为1.12(95%CI 1.10-1.14),低于BMI(OR=1.81)和年龄(OR=2.38)。
- 遗传因素OR在<60岁患者中大于≥60岁患者(p=0.002)。
核心结论
- 全基因组关联研究识别出多个与初次全膝关节置换术治疗的终末期膝骨关节炎显著相关的遗传变异。
- 年龄和BMI对终末期膝骨关节炎风险的影响似乎大于遗传因素。
- 遗传因素对严重疾病发展的贡献在年轻患者中更大。
研究设计与样本
- 在U.K. Biobank中通过行政代码识别诊断为膝骨关节炎并接受初次全膝关节置换术的个体,U.K. Biobank是包含>500,000名患者前瞻性收集临床和基因组数据的数据存储库。
- 使用REGENIE软件包进行全基因组关联分析,并使用逻辑回归比较按年龄和BMI分层的亚组之间的总遗传风险。
- 共识别16,032例接受初次全膝关节置换术的终末期膝骨关节炎患者。
- 证据等级:预后Level III。
主要发现
- 发现7个遗传位点与终末期膝骨关节炎显著相关。
- 遗传因素所致终末期膝骨关节炎的OR为1.12(95%CI 1.10-1.14)。
- BMI的OR为1.81(95%CI 1.78-1.83),年龄的OR为2.38(95%CI 2.32-2.45)。
- 遗传因素所致终末期膝骨关节炎的OR在<60岁患者中大于≥60岁患者(p=0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: End-stage knee osteoarthritis (OA) is a highly debilitating disease for which total knee arthroplasty (TKA) serves as an effective treatment option. Although a genetic component to OA in general has been described, evaluation of the genetic contribution to end-stage OA of the knee is limited. To this end, we present a genome-wide association study involving patients undergoing TKA for primary knee OA to characterize the genetic features of severe disease on a population level. METHODS: Individuals with the diagnosis of knee OA who underwent primary TKA were identified in the U.K. Biobank using administrative codes. The U.K. Biobank is a data repository containing prospectively collected clinical and genomic data for >500,000 patients. A genome-wide association analysis was performed using the REGENIE software package. Logistic regression was also used to compare the total genetic risk between subgroups stratified by age and body mass index (BMI). RESULTS: A total of 16,032 patients with end-stage knee OA who underwent primary TKA were identified. Seven genetic loci were found to be significantly associated with end-stage knee OA. The odds ratio (OR) for developing end-stage knee OA attributable to genetics was 1.12 (95% confidence interval [CI], 1.10 to 1.14), which was lower than the OR associated with BMI (OR = 1.81; 95% CI, 1.78 to 1.83) and age (OR = 2.38; 95% CI, 2.32 to 2.45). The magnitude of the OR for developing end-stage knee OA attributable to genetics was greater in patients <60 years old than in patients ≥60 years old (p = 0.002). CONCLUSIONS: This population-level genome-wide association study of end-stage knee OA treated with primary TKA was notable for identifying multiple significant genetic variants. These loci involve genes responsible for cartilage development, cartilage homeostasis, cell signaling, and metabolism. Age and BMI appear to have a greater impact on the risk of developing end-stage disease compared with genetic factors. The genetic contribution to the development of severe disease is greater in younger patients. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Kulm S, Kolin DA, Langhans MT, et al. Characterization of Genetic Risk of End-Stage Knee Osteoarthritis Treated with Total Knee Arthroplasty: A Genome-Wide Association Study. J Bone Joint Surg Am. 2022. PMID: 36000784. doi:10.2106/JBJS.22.00364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。